ERS spotlights AI lung disease detection; employer cancer benefits; outpatient CAR T; tafasitamab response similar across races; HFpEF missed at referral.
Feature|Articles|April 7, 2026
ACIP Changes Disrupt Vaccine Coverage Pipeline, Raise Cost Concerns
Author(s)Giuliana Grossi
Fact checked by: Christina Mattina
ACIP changes threaten vaccine coverage and raise costs, according to a roundtable of experts warning of widening disparities and long-term public health risks.
Advertisement
Advertisement
For decades, the CDC Advisory Committee on Immunization Practices (ACIP) served as the linchpin of pediatric vaccine policy, and by extension, the basis on which insurers determined what they would cover. When ACIP recommended a vaccine, coverage followed. That equation is now broken, and the financial fallout will be felt most acutely by families least equipped to absorb it, according to a panel of experts.
Related to this article
Vitamin K shot refusals rose 77% from 2017 to 2024. Experts break down the drivers, risks, and how clinicians and payers should respond in 5 FAQs.
Oral GLP-1s, Medicare access, and lingering weight bias are reshaping obesity care, says NYU Langone's Holly Lofton, MD.
Karen van Caulil, PhD, on how employers can improve cancer care by investing in access, prevention, and support through treatment and survivorship.
Working-age adults with private insurance are paying off medical debt, often draining savings, delaying care, or cutting back on necessities as a result.
Patient factors and access barriers are reshaping treatment sequencing and individualized care for relapsed multiple myeloma, Amandeep Godara, MBBS, said.
Each additional hour of nightly CPAP use was associated with 13% lower all-cause mortality risk in a French cohort of adults with sleep apnea.
Nicola Hanania, MD, discusses why delayed dupilumab initiation after an asthma exacerbation raises costs and outcomes risk.
Advertisement
Advertisement